Baidu
map
ANTIMICROB AGENTS CH 润色咨询

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

出版年份：1972 年文章数：14802 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：12.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2019-03-14 stupidzhang

    投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2021-12-29 rayms

    SD/SEM是什么，有什么区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2021-12-29 小动量

    什么是三线表？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2017-12-01 kobe24song

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2020-01-10 youliangshun

    今年IF会涨吗

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2019-01-10 monamina

    审稿速度:1.0
    经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2018-08-22 yh03021307

    一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2017-07-16 wang_di98

    徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2017-05-14 youliangshun

    已接收！等onlineyouliangshun 2017-03-16 发表::
    二审7天了。。。

    youliangshun 2017-03-16 发表:: 二审7天了。。。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=568059, encodeId=10e356805933, content=投稿总是失败，都被退回，显示“awaiting for author approval”,但是每次每次投稿都是approve了的。然后隔天就被退回，怎么解决？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCVFdom4hkiaYbVOXicssflT4KFQsXl6F37kicyHbPj9pabz6YFnWlz5K5MgeC3t4Hr5TUoJrIlRHhw/132, createdBy=6042106193, createdName=stupidzhang, createdTime=Thu Mar 14 09:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086908, encodeId=f0cf1086908f7, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086907, encodeId=cc29108690ee5, content=什么是三线表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549613, encodeId=101754961304, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚刚被拒了一篇，审稿20天。做的是天然产物抗菌，被拒的理由是菌株太少，结果不具有代表性，需要测更多的菌株。两个审稿人，一个同意发表；另一个认为菌太少，结果不可靠，需要增加菌株。最后编辑同意第二个审稿人意见，拒稿。收费貌似不菲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Fri Dec 01 06:23:00 CST 2017, time=2017-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582995, encodeId=02a4582995f8, content=今年IF会涨吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565402, encodeId=f2b65654020c, content=审稿速度:1.0<br>经验分享：一审1个月，大修，修回之后1天就accept了，惊人的速度……可能是因为论文研究方向比较新颖？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d0e1681215, createdName=monamina, createdTime=Thu Jan 10 11:59:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560306, encodeId=7199560306c9, content=一审43天依然under review，这个杂志最近审稿效率降低了吗？以前印象好像是一审基本3-4周的样子。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3012874, createdName=yh03021307, createdTime=Wed Aug 22 05:42:00 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543963, encodeId=ea215439632b, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536720, encodeId=4556536e206c, content=已接收！等online<span class="quote">youliangshun 2017-03-16 发表::<br>二审7天了。。。</span>, beContent=youliangshun 2017-03-16 发表:: 二审7天了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Sun May 14 13:55:00 CST 2017, time=2017-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534319, encodeId=c4655343193d, content=二审7天了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DDB4A9938F1863.jpg, createdBy=72e11984217, createdName=youliangshun, createdTime=Thu Mar 16 20:18:00 CST 2017, time=2017-03-16, status=1, ipAttribution=)]
    2017-03-16 youliangshun

    二审7天了。。。

    0

共52条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map